These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3707279)

  • 1. [Value of mexiletine in the treatment of Thomsen-Becker myotonia].
    Leheup B; Himon F; Morali A; Brichet F; Vidailhet M
    Arch Fr Pediatr; 1986 Jan; 43(1):49-50. PubMed ID: 3707279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
    Pouget J; Serratrice G
    Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effective treatment of paramyotonia congenita by mexiletene].
    Nezu A; Yamashita S; Miyake S; Hayashi M; Iwamoto H
    No To Hattatsu; 1986 May; 18(3):236-7. PubMed ID: 3707771
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
    Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
    Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine.
    Ceccarelli M; Rossi B; Siciliano G; Calevro L; Tarantino E
    Acta Paediatr; 1992 May; 81(5):453-5. PubMed ID: 1498517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of myotonia congenita].
    Rossi B; Sartucci F; Siciliano G
    Minerva Pediatr; 1986 Aug; 38(15-16):673-8. PubMed ID: 3796521
    [No Abstract]   [Full Text] [Related]  

  • 7. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Andersen G; Hedermann G; Witting N; Duno M; Andersen H; Vissing J
    Brain; 2017 Sep; 140(9):2295-2305. PubMed ID: 29050397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of myotonia with antiarrhythmic drugs.
    Kwieciński H; Ryniewicz B; Ostrzycki A
    Acta Neurol Scand; 1992 Oct; 86(4):371-5. PubMed ID: 1455983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy.
    Jackson CE; Barohn RJ; Ptacek LJ
    Muscle Nerve; 1994 Jul; 17(7):763-8. PubMed ID: 8008003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
    Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A
    Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of resistant supraventricular tachycardia with mexiletine.
    Slater SD; Simmons W; McCall JG; Zmily SM
    Br J Clin Pract; 1980 Aug; 34(8-9):247-50. PubMed ID: 7426294
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiological evaluation of congenital myotonia.
    Rossi B; Siciliano G; Sartucci F
    Electromyogr Clin Neurophysiol; 1985; 25(6):413-22. PubMed ID: 4065028
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fiction: the Christmas card.
    Brooke MH
    Neurology; 2005 Mar; 64(5):929-30. PubMed ID: 15753449
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita.
    Ginanneschi F; Mignarri A; Lucchiari S; Ulzi G; Comi GP; Rossi A; Dotti MT
    Neurophysiol Clin; 2017 Jun; 47(3):247-252. PubMed ID: 28153715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of ventricular arrhythmias with mexiletine].
    Trenckmann H; Neugebauer A; Krosse B
    Z Gesamte Inn Med; 1982 May; 37(9):259-62. PubMed ID: 7048773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.